✦ LIBER ✦

Acyclovir Prophylaxis for Cytomegalovirus in Liver Transplant Recipients

✍ Scribed by Singh, N.; Yu, V. L.

Book ID: 115450785
Publisher: University of Chicago Press
Year: 1994
Tongue: English
Weight: 93 KB
Volume: 169
Category: Article
ISSN: 0022-1899
DOI: 10.1093/infdis/169.6.1406

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised comparison of ganciclovir and

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

✍ D.J. Winston; D. Wirin; A. Shaked; R.W. Busuttil 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 876 KB

Acyclovir prophylaxis of cytomegalovirus

Acyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipients

✍ A Vila; L.L Guirado; A Balius; M Dı́az; E Baró; M Olaya; M Andrade; I Agraz; R S 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Valganciclovir for cytomegalovirus proph

Valganciclovir for cytomegalovirus prophylaxis in liver transplant recipients

✍ Jeong M. Park; Kathleen D. Lake; Robert J. Fontana 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

We thank Jain et al. for their interest and correspondence regarding our recently published study. 1 The authors note that the incidence of cytomegalovirus (CMV) disease in our retrospective study was much lower than that reported by others. As acknowledged in our article, we did not use routine sur

Cytomegalovirus (CMV) prophylaxis by acy

Cytomegalovirus (CMV) prophylaxis by acyclovir in pre-transplant CMV-positive renal transplant recipients

✍ L. Rostaing; A. Crespin; J. Icart; J. J. Lloveras; D. Durand; O. Martinet; J. Di 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 403 KB

252Valacyclovir compared to acyclovir fo

252Valacyclovir compared to acyclovir for cytomegalovirus prophylaxis in allogeneic stem cell transplants recipients

✍ A.S. Artz; N. Dieterle; J. Gelms; S. Parsad; R. Larson; W. Stock; C. Daugherty; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Valganciclovir is an effective prophylax

Valganciclovir is an effective prophylaxis for cytomegalovirus disease in liver transplant recipients

✍ Sameh Adel Fayek; Wana Mantipisitkul; Flavia Rasetto; Raghava Munivenkatappa; Ro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB